Zhao Guobin, Zhou Yan, Tang Yuhong, Abbas Muhammad, Dong Shaowen, Zhao Xinyang, Liu Xin, Wang Xinmei, Li Chen, Liu Chenxi
Department of Urology, The First Affiliated Hospital of Hebei North University, Zhangjiakou, Hebei 075000, P.R. China.
Department of Immunology, Hebei North University, Zhangjiakou, Hebei 075000, P.R. China.
Oncol Lett. 2024 Oct 25;29(1):28. doi: 10.3892/ol.2024.14774. eCollection 2025 Jan.
polysaccharides (PSP) are a traditional herbal medicine component with potential therapeutic effects on several diseases. The present study aimed to assess the role of PSP in the treatment of human prostate cancer using a PC-3 cell line by Cell CK-8, transwell and wound healing assays, then elucidate the potential underlying mechanisms by western blot and quantitative Real-time RT-PCR. Different concentrations of PSP were applied to PC-3 cells, and the proliferation, invasion and migration of PC-3 cells were demonstrated to be significantly inhibited with increasing concentrations of PSP. Additionally, cell apoptosis rate and expression of caspase-3 increased with higher PSP concentrations, and the cell cycle was arrested in the S phase. Furthermore, it was demonstrated that the expression of the multidrug resistance-1 gene and its encoded protein P-glycoprotein in PC-3 cells decreased following PSP treatment, suggesting that PSP may have the potential to reverse multidrug resistance in PC-3 cells. The present study also evaluated the possible mechanism of PSP action on PC-3 cells. The results revealed that phosphorylated P65, PI3K and AKT decreased in a concentration-dependent manner. As key molecules in the NF-κB and PI3K/Akt signaling pathways, this finding suggests that the potential mechanism of the effect of PSP on prostate cancer cells may involve simultaneous mediation of the PI3K/Akt and NF-κB signaling pathways. The present study demonstrated that PSP inhibit the proliferation, invasion and migration of PC-3 cells , as well as reverse MDR in these cells. The underlying mechanism may involve the simultaneous regulation of the PI3K/Akt and NF-κB signaling pathways.
多糖(PSP)是一种传统草药成分,对多种疾病具有潜在治疗作用。本研究旨在通过细胞CK-8、Transwell和伤口愈合试验,评估PSP在使用PC-3细胞系治疗人类前列腺癌中的作用,然后通过蛋白质印迹法和定量实时逆转录聚合酶链反应阐明潜在的作用机制。将不同浓度的PSP应用于PC-3细胞,结果表明,随着PSP浓度的增加,PC-3细胞的增殖、侵袭和迁移受到显著抑制。此外,细胞凋亡率和半胱天冬酶-3的表达随着PSP浓度的升高而增加,细胞周期停滞在S期。此外,研究表明,PSP处理后,PC-3细胞中多药耐药-1基因及其编码蛋白P-糖蛋白的表达降低,这表明PSP可能具有逆转PC-3细胞多药耐药的潜力。本研究还评估了PSP对PC-3细胞作用的可能机制。结果显示,磷酸化的P65、PI3K和AKT呈浓度依赖性降低。作为核因子-κB和PI3K/Akt信号通路中的关键分子,这一发现表明,PSP对前列腺癌细胞作用的潜在机制可能涉及同时介导PI3K/Akt和核因子-κB信号通路。本研究表明,PSP可抑制PC-3细胞的增殖、侵袭和迁移,并逆转这些细胞中的多药耐药。潜在机制可能涉及同时调节PI3K/Akt和核因子-κB信号通路。